Wethersfield, CT, United States of America

Timothy P Spicer


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Timothy P. Spicer

Introduction

Timothy P. Spicer is a notable inventor based in Wethersfield, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral compounds. His work focuses on creating innovative solutions to combat viral infections, including HIV and AIDS.

Latest Patents

Timothy P. Spicer holds a patent for "Antiviral indoleoxoacetyl piperazine derivatives." This invention provides compounds that possess drug and bio-affecting properties, along with their pharmaceutical compositions and methods of use. The indoleoxoacetyl piperazine derivatives developed by Spicer exhibit unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators, or HIV entry inhibitors. This patent is particularly relevant for the treatment of HIV and AIDS.

Career Highlights

Spicer is associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work at this esteemed organization has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Throughout his career, Timothy P. Spicer has collaborated with esteemed colleagues, including Wade S. Blair and Milind Deshpande. These collaborations have further enhanced his research and innovation in the field of antiviral therapies.

Conclusion

Timothy P. Spicer's contributions to antiviral research and his innovative patent for indoleoxoacetyl piperazine derivatives highlight his commitment to improving healthcare solutions. His work continues to have a significant impact on the treatment of viral infections, particularly HIV and AIDS.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…